Kimothy Lee Davis

Kimothy Lee Davis serves as a Contract Analyst within the Defense Health Agency (HT9406), supporting the procurement of critical research and development services essential to maintaining operational medical readiness across the Department of Defense. In this role, Davis manages the full lifecycle of acquisitions for technical and scientific solutions, ensuring compliance with federal contracting regulations while aligning procurements with the agency’s strategic priorities in clinical innovation, pharmaceutical supply resilience, and advanced diagnostic infrastructure. Their work primarily involves soliciting, evaluating, and awarding contracts for life sciences R&D activities that enhance military healthcare delivery and force readiness. Davis maintains consistent working relationships with a select group of specialized contractors, including Dependable On-Site Scan & Shred, Inc., Hanith Bioscience, LLC, Livion Technology, LLC, I-2-I Solutions, Inc., and Draeger Inc. These partnerships reflect a focus on firms capable of delivering high-compliance, mission-critical services in areas such as biomedical research, clinical data systems, medical device support, and secure health information management. The working relationships are characterized by repeat engagement and technical alignment, indicating a preference for vendors with proven expertise in defense-specific healthcare environments. Davis’s procurement activity is entirely non-set-aside, with 100% of awards issued under full and open competition. This reflects a strategic emphasis on selecting the most technically qualified providers regardless of socioeconomic status, prioritizing mission performance and scientific rigor over socioeconomic preferences. The agency’s contracting activity under Davis’s purview is exclusively focused on NAICS 541715—Research and Development in the Physical, Engineering, and Life Sciences. This specialization underscores deep expertise in procuring advanced scientific services, including clinical trial support, biostatistical analysis, medical device prototyping, and health systems engineering, all critical to modernizing DHA’s global medical infrastructure.